|
1
|
Balkwill F and Coussens LM: Cancer: an
inflammatory link. Nature. 431:405–406. 2004.
|
|
2
|
Arbour NC, Lorenz E, Schutte BC, et al:
TLR4 mutations are associated with endotoxin hyporesponsiveness in
humans. Nat Genet. 25:187–191. 2000.
|
|
3
|
Lorenz E, Patel DD, Hartung T and Schwartz
DA: Toll-like receptor 4 (TLR4)-deficient murine macrophage cell
line as an in vitro assay system to show TLR4-independent
signaling of Bacteroides fragilis lipopolysaccharide. Infect
Immun. 70:4892–4896. 2002.
|
|
4
|
Poveda Velasco A, Casado Herráez A,
Cervantes Ruipérez A, et al: Treatment guidelines in ovarian
cancer. Clin Transl Oncol. 9:308–316. 2007.
|
|
5
|
Lehnerdt GF, Franz P, Zaqoul A, et al:
Overall and relapse-free survival in oropharyngeal and
hypopharyngeal squamous cell carcinoma are associated with
genotypes of T393C polymorphism of the GNAS1 gene. Clin Cancer Res.
14:1753–1758. 2008.
|
|
6
|
Montes AH, Asensi V, Alvarez V, et al: The
Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for
Gram-negative and haematogenous osteomyelitis. Clin Exp Immunol.
143:404–413. 2006.
|
|
7
|
Fukata M, Chen A, Vamadevan AS, et al:
Toll-like receptor-4 promotes the development of colitis-associated
colorectal tumors. Gastroenterology. 133:1869–1881. 2007.
|
|
8
|
Lee SJ and Lim KT: UDN glycoprotein
regulates activities of manganese-superoxide dismutase, activator
protein-1, and nuclear factor-kappaB stimulated by reactive oxygen
radicals in lipopolysaccharide-stimulated HCT-116 cells. Cancer
Lett. 254:274–287. 2007.
|
|
9
|
Wang JH, Manning BJ, Wu QD, Blankson S,
Bouchier-Hayes D and Redmond HP: Endotoxin/lipopolysaccharide
activates NF-kappa B and enhances tumor cell adhesion and invasion
through a beta 1 integrin-dependent mechanism. J Immunol.
170:795–804. 2003.
|
|
10
|
Cianchi F, Cortesini C, Fantappiè O, et
al: Cyclooxygenase-2 activation mediates the proangiogenic effect
of nitric oxide in colorectal cancer. Clin Cancer Res.
10:2694–2704. 2004.
|
|
11
|
Molteni M, Marabella D, Orlandi C and
Rossetti C: Melanoma cell lines are responsive in vitro to
lipopolysaccharide and express TLR-4. Cancer Lett. 235:75–83.
2006.
|
|
12
|
Huang B, Zhao J, Li H, et al: Toll-like
receptors on tumor cells facilitate evasion of immune surveillance.
Cancer Res. 65:5009–5014. 2005.
|
|
13
|
Castro FA, Försti A, Buch S, et al: TLR-3
polymorphism is an independent prognostic marker for stage II
colorectal cancer. Eur J Cancer. 47:1203–1210. 2011.
|
|
14
|
Apetoh L, Ghiringhelli F, Tesniere A, et
al: Toll-like receptor 4-dependent contribution of the immune
system to anticancer chemotherapy and radiotherapy. Nat Med.
13:1050–1059. 2007.
|
|
15
|
Hellmig S, Fischbach W, Goebeler-Kolve ME,
Fölsch UR, Hampe J and Schreiber S: Association study of a
functional Toll-like receptor 4 polymorphism with susceptibility to
gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma.
46:869–872. 2005.
|
|
16
|
Kato I, Canzian F, Plummer M, et al:
Polymorphisms in genes related to bacterial
lipopolysaccharide/peptidoglycan signaling and gastric precancerous
lesions in a population at high risk for gastric cancer. Dig Dis
Sci. 52:254–261. 2007.
|
|
17
|
Trejo-de la OA, Torres J, Pérez-Rodríguez
M, et al: TLR4 single-nucleotide polymorphisms alter mucosal
cytokine and chemokine patterns in Mexican patients with
Helicobacter pylori-associated gastroduodenal diseases. Clin
Immunol. 129:333–340. 2008.
|
|
18
|
Achyut BR, Ghoshal UC, Moorchung N and
Mittal B: Association of Toll-like receptor-4 (Asp299Gly and
Thr399Ileu) gene polymorphisms with gastritis and precancerous
lesions. Hum Immunol. 68:901–907. 2007.
|
|
19
|
Santini D, Angeletti S, Ruzzo A, et al:
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in
gastric cancer of intestinal and diffuse histotypes. Clin Exp
Immunol. 154:360–364. 2008.
|
|
20
|
Tahara T, Arisawa T, Shibata T, Hirata I
and Nakano H: Absence of common polymorphisms of toll like receptor
4 (TLR4): Asp299Gly, Thr399Ile in patients with gastroduodenal
diseases in Japan. J Clin Biochem Nutr. 40:62–65. 2007.
|
|
21
|
Guo Q, Zhu J and Xia B: Polymorphism of
CD14 gene but not the mutation of TLR4 gene is associated with
colorectal cancer in Chinese patients. J Gastroenterol Hepatol.
21:92–77. 2006.
|
|
22
|
Zhang K, Zhou B, Wang Y, Rao L and Zhang
L: The TLR4 gene polymorphisms and susceptibility to cancer: a
systematic review and meta-analysis. Eur J Cancer. 49:946–954.
2013.
|
